Biohaven (BHVN) Operating Income (2021 - 2026)
Biohaven (BHVN) reported Operating Income of -$130.4 million for Q1 2026, up 41.13% on a YoY basis from -$92.4 million in Q1 2025, and up 8.62% sequentially from -$142.7 million in Q4 2025.
Biohaven (BHVN) Operating Income (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Operating Income data on file, last reported at -$130.4 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 41.13% year-over-year to -$130.4 million; the trailing twelve-month figure through Mar 2026 stood at -$654.2 million (up 29.15% YoY), and the FY2025 full-year result was -$745.4 million, up 15.79% from the prior year.
- Operating Income improved to -$130.4 million in Q1 2026, from -$142.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$67.6 million in Q3 2022 to a low of -$333.8 million in Q2 2024.
- A 5-year average of -$162.6 million and a median of -$169.4 million in 2025 frame the typical range for Operating Income.
- Across the five-year window, Operating Income plunged 319.42% in 2022 and soared 52.31% in 2023, its largest moves.
- Tracing BHVN's Operating Income over 5 years: stood at -$213.4 million in 2022, then climbed by 27.97% to -$153.7 million in 2023, then slipped by 23.56% to -$189.9 million in 2024, then increased by 24.85% to -$142.7 million in 2025, then climbed by 8.62% to -$130.4 million in 2026.
- Business Quant data shows BHVN's Operating Income at -$130.4 million in Q1 2026, -$142.7 million in Q4 2025, and -$169.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -130.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.43 Mn |
| Dec 31, 2025 | -142.73 Mn |
| Sep 30, 2025 | -169.38 Mn |
| Jun 30, 2025 | -211.70 Mn |
| Mar 31, 2025 | -221.56 Mn |
| Dec 31, 2024 | -189.93 Mn |
| Sep 30, 2024 | -178.17 Mn |
| Jun 30, 2024 | -333.77 Mn |
| Mar 31, 2024 | -183.24 Mn |
| Dec 31, 2023 | -153.71 Mn |
| Sep 30, 2023 | -110.55 Mn |
| Jun 30, 2023 | -94.01 Mn |
| Mar 31, 2023 | -77.78 Mn |
| Dec 31, 2022 | -213.41 Mn |
| Sep 30, 2022 | -67.64 Mn |
| Jun 30, 2022 | -197.11 Mn |
| Mar 31, 2022 | -89.77 Mn |
| Dec 31, 2021 | -50.88 Mn |
| Sep 30, 2021 | -55.49 Mn |